Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery.
BACKGROUND:Chagas disease is a neglected tropical disease (NTD) caused by the eukaryotic parasite Trypanosoma cruzi. The current clinical and preclinical pipeline for T. cruzi is extremely sparse and lacks drug target diversity. METHODOLOGY/PRINCIPAL FINDINGS:In the present study we developed a comp...
Saved in:
Main Authors: | Sean Ekins (Author), Jair Lage de Siqueira-Neto (Author), Laura-Isobel McCall (Author), Malabika Sarker (Author), Maneesh Yadav (Author), Elizabeth L Ponder (Author), E Adam Kallel (Author), Danielle Kellar (Author), Steven Chen (Author), Michelle Arkin (Author), Barry A Bunin (Author), James H McKerrow (Author), Carolyn Talcott (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long term follow-up of Trypanosoma cruzi infection and Chagas disease manifestations in mice treated with benznidazole or posaconazole.
by: Claudia Magalhães Calvet, et al.
Published: (2020) -
Diverse inhibitor chemotypes targeting Trypanosoma cruzi CYP51.
by: Shamila S Gunatilleke, et al.
Published: (2012) -
Structural characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei bound to the antifungal drugs posaconazole and fluconazole.
by: Chiung-Kuang Chen, et al.
Published: (2010) -
In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi.
by: Yen Ting Chen, et al.
Published: (2010) -
Trypanosoma cruzi CYP51 inhibitor derived from a Mycobacterium tuberculosis screen hit.
by: Chiung-Kuang Chen, et al.
Published: (2009)